Table 2.
Variable | N | Follow-up testing by day 120, % | Unadjusted P-value* | Adjusted Odds ratio (95% CI)** |
---|---|---|---|---|
Age, years | ||||
<50 | 786 | 57.2 | .01 | 1.3 (1.1–1.6) |
≥50 | 656 | 48.8 | referent | |
| ||||
HPV status | ||||
HPV negative | 126 | 42.1 | .02 | 1.0 (0.65–1.6) |
HPV positive | 26 | 84.6 | <.01 | 6.1 (2.0–18.5) |
No HPV testing | 1290 | 53.9 | referent | |
| ||||
Prior cervical biopsy results | ||||
Prior biopsy with CIN2+ | 17 | 76.5 | .09 | 2.7 (.89–8.2) |
No known CIN2+ | 1425 | 53.1 | referent | |
| ||||
Indication for Pap testing | ||||
Diagnostic Pap | 129 | 51.9 | .39 | 0.8 (0.52–1.3) |
Screening Pap | 1313 | 53.5 | referent | |
| ||||
Results of prior Pap test(s) | ||||
Any prior result abnormal | 15 | 60.0 | .46 | 1.2 (0.31–4.8) |
No prior results | 978 | 56.2 | <.01 | 1.1 (0.70–1.8) |
All prior results normal | 449 | 47.0 | referent | |
| ||||
Time since prior Pap | ||||
0–18 months | 347 | 48.1 | .01 | 0.9 (0.57–1.5) |
19+ months | 1068 | 55.2 | referent |
Note.
Univariate testing compared to referent group;
Adjusted for all variables listed in table, study site, test year and repeated measures
HPV = Human Papilloma Virus; CIN2+ = Cervical Intra-epithelial Neoplasia 2 or worse